Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Agar Plate
5%
Antibiotic Resistance
42%
Antibiotic Sensitivity
26%
Antigen
20%
Antimicrobial Agent
18%
Arm
9%
Bacterium
12%
Bartonella
5%
Blood Plasma
10%
CD4
5%
Chikungunya virus
9%
Chlamydia Trachomatis
11%
Chlamydiae
7%
Cladistics
26%
Cohort Effect
9%
Coinfection
10%
COVID-19
9%
Coxiella burnetii
6%
Cross-Reactivity
5%
Cutaneous Leishmaniasis
6%
Cytotoxic T-Cell
5%
Dengue Fever
9%
Dengue Virus
11%
Dengue Virus 1
5%
Drug Resistance
9%
ELISA
6%
Epidemiology
6%
Epitope
9%
Escherichia coli
9%
Galleria mellonella
26%
Genome Sequencing
6%
Helminth
5%
Hepatitis C Virus
7%
Horizontal Gene Transfer
6%
Human immunodeficiency virus
55%
Human Immunodeficiency Virus 1
11%
Immunoassay
9%
In Vitro
28%
Infection
98%
Infectious Agent
10%
Infectious Disease
100%
Klebsiella pneumoniae
14%
Leishmania
7%
Leishmaniasis
12%
Lineage
9%
Malaria
11%
Metagenomics
5%
Minimum Inhibitory Concentration
50%
Monkeypox
18%
Monkeypox Virus
24%
Multiplex Polymerase Chain Reaction
5%
Mycoplasma genitalium
11%
Neisseria
51%
Neisseria gonorrhoeae
78%
Neutralizing Antibody
5%
Parasite
13%
Parasitology
9%
Peptides
7%
Prevalence
37%
Real Time Polymerase Chain Reaction
8%
Real-Time Polymerase Chain Reaction
5%
Ribonucleic Acid
7%
Salmonella
7%
Salmonella enterica serovar typhimurium
5%
Schistosoma
8%
Schistosomiasis
15%
Serology
11%
Serotype
10%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Sexual Health
6%
Susceptibility
18%
T Cell Receptor
5%
Vaccinia virus
5%
Viral Shedding
6%
Virus Infection
14%
Visceral Leishmaniasis
17%
Whole Genome Sequencing
21%
Zika virus
6%
Medicine and Dentistry
Adolescence
6%
Antibiotic Resistance
18%
Antigen
10%
Antiinfective Agent
11%
Arm
5%
Artesunate
5%
Awareness
6%
Azithromycin
5%
Bartonella
5%
Chlamydia Trachomatis
12%
Chlamydiae
9%
Clinical Trial
7%
Clinician
6%
Cohort Effect
11%
COVID-19
8%
Coxiella burnetii
8%
Cross Sectional Study
6%
Diseases
33%
Doxycycline
7%
Genetics
8%
Gonorrhea
14%
Human immunodeficiency virus
44%
Immunoglobulin M
5%
Infection
58%
Listerine
5%
Macrolide
13%
Malaria
13%
Malaria Falciparum
7%
Men Who Have Sex with Men
39%
Monkeypox
17%
Monkeypox Virus
16%
Mouthwash
5%
Mycoplasma genitalium
11%
Neisseria
6%
Neisseria gonorrhoeae
17%
Observational Study
6%
Oral
8%
Parasite (Microbiology)
12%
Parasitic Disease
5%
Parasitic Disease
5%
Pathogen
7%
Pediatrics
5%
Plasmodium
7%
Polymerase Chain Reaction
6%
Pre-Exposure Prophylaxis
28%
Pregnant Woman
5%
Prevalence
23%
Primary Health Care
5%
Prospective Cohort Study
15%
Public Health
10%
Quinolone Derivative
11%
Randomized Controlled Trial
7%
Retrospective Cohort Study
5%
Returning Traveler
14%
Schistosoma
5%
Schistosomiasis
10%
Sex Worker
5%
Sexual Behavior
6%
Sexually Transmitted Disease
26%
Sexually Transmitted Infection
6%
Skin Defect
8%
Syphilis
8%
Tick Borne Encephalitis
10%
Transgender
6%
Tropical Disease
11%
Virus Shedding
5%
Whole Genome Sequencing
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
14%
Antiinfective Agent
19%
Antimicrobial Agent
5%
Artemether Plus Benflumetol
5%
Artesunate
8%
Azithromycin
11%
Ceftriaxone
7%
Chlamydia Trachomatis
5%
Ciprofloxacin
10%
Combination Therapy
5%
Cross Sectional Study
5%
Cross-Sectional Study
6%
Doxycycline
8%
Galleria mellonella
17%
Gonorrhea
13%
HIV
22%
Infection
23%
Klebsiella pneumoniae
8%
Listerine
5%
Macrolide
17%
Malaria
5%
Malaria Falciparum
9%
Mefloquine
5%
Mouthwash
5%
Mycoplasma genitalium
13%
Neisseria
5%
Neisseria gonorrhoeae
21%
Praziquantel
6%
Prevalence
25%
Quinolone
5%
Quinolone Derivative
15%
Randomized Controlled Trial
9%
SARS Coronavirus
5%
Schistosomiasis
8%
Sexually Transmitted Disease
9%